Drug targets identified by us that are already in use for the different IMIDs include drugs that target IL1B, IL6, TYK2, and JAK2.IL1B was present in the common cell-gene network of AS, CD, psoriasis, RA, and UC, indicating a similar mechanism between these diseases (Table 1). Here, IL1B is linked to psoriasis.